| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892
Primary mouse keratinocytes expressing the v-rasHa oncogene (v-rasHa keratinocytes) produce squamous papillomas when grafted onto nude mice and respond abnormally to signals for terminal differentiation both in vivo and in vitro. Since protein kinase C (PKC) activators and v-rasHa induce similar phenotypic changes in cultured keratinocytes, and cellular diacylglycerol levels are constitutively elevated in ras-transformed keratinocytes, we tested whether PKC is a downstream target for oncogenic ras in this cell type. Ca2+-dependent PKC activity was increased in lysates from cultured v-rasHa keratinocytes when compared to control cells; in contrast, Ca2+-independent activity decreased. Similar to PKC activators, v-rasHa blocked Ca2+-mediated expression of the early epidermal differentiation markers keratins K1 and K10 while inducing aberrant expression of K8. Pretreatment of v-rasHa keratinocytes with bryostatin to block PKC function restored Ca2+-mediated expression of K1 and K10 and blocked abnormal expression of K8, suggesting that these responses are mediated by the PKC pathway. Furthermore, expression of K1 is restored at bryostatin doses which specifically down-modulate PKC-
, the only Ca2+-dependent PKC isozyme detected in cultured keratinocytes. In contrast to the inhibition of K1 and K10, Ca2+-induced expression of the late epidermal differentiation markers loricrin, filaggrin, and keratinocyte transglutaminase was accelerated by v-rasHa, as previously reported in normal keratinocytes treated with PKC activators. Pretreatment of v-rasHa keratinocytes with bryostatin blocked expression of late markers in these cells, and this response was correlated with down-regulation of PKC-
. The results of this study suggest that oncogenic ras alters keratinocyte differentiation by altering the function of the PKC signaling pathway, and that PKC-
is the specific isozyme involved in down-modulating expression of keratins K1 and K10 and up-regulating expression of loricrin, filaggrin, and keratinocyte transglutaminase.
1 To whom requests for reprints should be addressed, at Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, NIH, Building 37, Room 3B08, Bethesda, MD 20892. Recipient of a Thomas B. Fitzpatrick-Kao Corporation Research Award.
Received 9/ 1/94. Accepted 11/ 4/94.
This article has been cited by other articles:
![]() |
E. E.W. Cohen, H. Zhu, M. W. Lingen, L. E. Martin, W.-L. Kuo, E. A. Choi, M. Kocherginsky, J. S. Parker, C. H. Chung, and M. R. Rosner A Feed-Forward Loop Involving Protein Kinase C{alpha} and MicroRNAs Regulates Tumor Cell Cycle Cancer Res., January 1, 2009; 69(1): 65 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, K. Sampat, N. Hu, J. Zakari, and S. H. Yuspa Protein Kinase C Negatively Regulates Akt Activity and Modifies UVC-induced Apoptosis in Mouse Keratinocytes J. Biol. Chem., February 10, 2006; 281(6): 3237 - 3243. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Scholl, P. A. Dumesic, and P. A. Khavari Mek1 Alters Epidermal Growth and Differentiation Cancer Res., September 1, 2004; 64(17): 6035 - 6040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cataisson, E. Joseloff, R. Murillas, A. Wang, C. Atwell, S. Torgerson, M. Gerdes, J. Subleski, J.-L. Gao, P. M. Murphy, et al. Activation of Cutaneous Protein Kinase C{alpha} Induces Keratinocyte Apoptosis and Intraepidermal Inflammation by Independent Signaling Pathways J. Immunol., September 1, 2003; 171(5): 2703 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chaturvedi, M. Cesnjaj, P. Bacon, J. Panella, D. Choubey, M. O. Diaz, and B. J. Nickoloff Role of INK4a/Arf Locus-Encoded Senescent Checkpoints Activated in Normal and Psoriatic Keratinocytes Am. J. Pathol., January 1, 2003; 162(1): 161 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Muller-Decker, G. Neufang, I. Berger, M. Neumann, F. Marks, and G. Furstenberger Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis PNAS, September 17, 2002; 99(19): 12483 - 12488. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, Y. Liu, M. Mori, and M. Kulesz-Martin Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates Carcinogenesis, April 1, 2002; 23(4): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mani, C. M. Rudin, K. Kunkel, J. T. Holmlund, R. S. Geary, H. L. Kindler, F. A. Dorr, and M. J. Ratain Phase I Clinical and Pharmacokinetic Study of Protein Kinase C-{alpha} Antisense Oligonucleotide ISIS 3521 Administered in Combination with 5-Fluorouracil and Leucovorin in Patients with Advanced Cancer Clin. Cancer Res., April 1, 2002; 8(4): 1042 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Birt, E. Duysen, W. Wang, and A. Yaktine Corticosterone Supplementation Reduced Selective Protein Kinase C Isoform Expression in the Epidermis of Adrenalectomized Mice Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 679 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Rutberg, T. L. Adams, A. Glick, M. T. Bonovich, C. Vinson, and S. H. Yuspa Activator Protein 1 Transcription Factors Are Fundamental to v-rasHa-induced Changes in Gene Expression in Neoplastic Keratinocytes Cancer Res., November 1, 2000; 60(22): 6332 - 6338. [Abstract] [Full Text] |
||||
![]() |
L. Lan, C. Trempus, and S. K. Gilmour Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice Cancer Res., October 1, 2000; 60(20): 5696 - 5703. [Abstract] [Full Text] |
||||
![]() |
J. Nemunaitis, J. T. Holmlund, M. Kraynak, D. Richards, J. Bruce, N. Ognoskie, T. J. Kwoh, R. Geary, A. Dorr, D. Von Hoff, et al. Phase I Evaluation of ISIS 3521, an Antisense Oligodeoxynucleotide to Protein Kinase C-Alpha, in Patients With Advanced Cancer J. Clin. Oncol., November 1, 1999; 17(11): 3586 - 3595. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Yuen, J. Halsey, G. A. Fisher, J. T. Holmlund, R. S. Geary, T. J. Kwoh, A. Dorr, and B. I. Sikic Phase I Study of an Antisense Oligonucleotide to Protein Kinase C-{{alpha}} (ISIS 3521/CGP 64128A ) in Patients with Cancer Clin. Cancer Res., November 1, 1999; 5(11): 3357 - 3363. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar and A. Holmgren Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters Carcinogenesis, September 1, 1999; 20(9): 1761 - 1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang and R. Smart Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion J. Cell Sci., January 10, 1999; 112(20): 3497 - 3506. [Abstract] [PDF] |
||||
![]() |
I. Matsumura, K. Nakajima, H. Wakao, S. Hattori, K. Hashimoto, H. Sugahara, T. Kato, H. Miyazaki, T. Hirano, and Y. Kanakura Involvement of Prolonged Ras Activation in Thrombopoietin-Induced Megakaryocytic Differentiation of a Human Factor-Dependent Hematopoietic Cell Line Mol. Cell. Biol., July 1, 1998; 18(7): 4282 - 4290. [Abstract] [Full Text] |
||||
![]() |
Extended Abstracts Toxicol Pathol, November 1, 1997; 25(6): 674 - 696. [PDF] |
||||
![]() |
H. Nakagawa, T. Inomoto, and A. K. Rustgi A CACCC Box-like cis-Regulatory Element of the Epstein-Barr Virus ED-L2 Promoter Interacts with a Novel Transcriptional Factor in Tissue-specific Squamous Epithelia J. Biol. Chem., June 27, 1997; 272(26): 16688 - 16699. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rosson, T. G. O'Brien, J. A. Kampherstein, Z. Szallasi, K. Bogi, P. M. Blumberg, and J. M. Mullin Protein Kinase C-alpha Activity Modulates Transepithelial Permeability and Cell Junctions in the LLC-PK1 Epithelial Cell Line J. Biol. Chem., June 6, 1997; 272(23): 14950 - 14953. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Denning, A. A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa Activation of the Epidermal Growth Factor Receptor Signal Transduction Pathway Stimulates Tyrosine Phosphorylation of Protein Kinase C [IMAGE] J. Biol. Chem., March 8, 1996; 271(10): 5325 - 5331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |